Cytokinetics share price
WebView the latest Cytokinetics Inc. (CYTK) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebCytokinetics, Inc. (CYTK) Stock Price & News - Google Finance Markets +0.85 Home CYTK • NASDAQ Cytokinetics, Inc. Follow Share $35.84 Apr 3, 9:39:48 AM GMT-4 · …
Cytokinetics share price
Did you know?
WebJul 1, 2024 · The initial conversion price represents a premium of 30.0% over the last reported sale price of $39.29 per share of Cytokinetics’ common stock on June 30, … WebCytokinetics Stock Is Surging. Heart-Drug Results Are Exciting Investors. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-4.25 Market Cap $3.46 B Shares Outstanding 95.16 …
Web18 hours ago · The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator ... WebSectors Healthcare Biotechnology & Medical Research Cytokinetics. CYTK — Cytokinetics Share Price. $39.24 0.00 0.00%. Last trade - ...
WebThe Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Cytokinetics Inc’s P/E ratio is -8.23. WebMar 31, 2024 · On Friday 03/31/2024 the closing price of the Cytokinetics Inc share was $35.19 on NAS. Compared to the opening price on Friday 03/31/2024 on NAS of $35.02, this is a gain of 0.48%.
WebMar 16, 2024 · Cytokinetics, Incorporated Common Stock (CYTK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
WebLeading the group were shares of Cytokinetics (CYTK), up about 32.9% and shares of Sunesis Pharmaceuticals (SNSS) up about 16.1% on the day. how to spawn a mending villager with commandsWebFind real-time CYTK - Cytokinetics Inc stock quotes, company profile, news and forecasts from CNN Business. CYTK - Cytokinetics Inc Stock quote - CNNMoney.com Markets rayman origins holly luyaWebGenerating Revenue. 4. Later Stage VC. 02-Mar-2011. $1M. $3.3M. Completed. Generating Revenue. To view Cytonics’s complete valuation and funding history, request access ». rayman legends princess inflationWebDescription. Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary ... rayman legends armored toadWebMar 29, 2024 · Price To Cash Flow (Per Share TTM) 0.00. Total Debt/Total Equity (Quarterly) 0.00. Long Term Debt/Equity (Quarterly) ... Cytokinetics Inc. is a late-stage biopharmaceutical company. The Company is ... rayman legends how to shoot your dragonWebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate how to spawn a mob with no ai bedrockWebFeb 28, 2024 · In fact, the Most Accurate Estimate for the current quarter is currently at a loss of $1.18 per share for CYTK, compared to a broader Zacks Consensus Estimate of a loss of $1.22 per share. rayman legends magician